131 related articles for article (PubMed ID: 6546694)
1. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.
Horgan C; Taylor RP
Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of anti-dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement-fixing antibody/dsDNA immune complexes.
Taylor RP; Horgan C
Mol Immunol; 1984 Oct; 21(10):853-62. PubMed ID: 6334233
[TBL] [Abstract][Full Text] [Related]
3. Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies.
Taylor RP; Horgan C; Buschbacher R; Brunner CM; Hess CE; O'Brien WM; Wanebo HJ
Arthritis Rheum; 1983 Jun; 26(6):736-44. PubMed ID: 6860375
[TBL] [Abstract][Full Text] [Related]
4. Stability of DNA/ANTI-DNA complexes. IV. Complement fixation.
Pedersen SE; Taylor RP; Morley KW; Wright EL
J Immunol Methods; 1980; 38(3-4):269-80. PubMed ID: 7440976
[TBL] [Abstract][Full Text] [Related]
5. A kinetic study of erythrocyte-DNA/anti-DNA immune complex association and dissociation reactions in systemic lupus erythematosus.
Meryhew NL; Westling PR; Eerdmans ME; Janecek EJ; Runquist OA
Biochim Biophys Acta; 1989 Jun; 991(3):470-6. PubMed ID: 2786431
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
Taylor RP; Horgan C; Hooper M; Burge J
J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
[TBL] [Abstract][Full Text] [Related]
7. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
8. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
Edberg JC; Wright E; Taylor RP
J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
[TBL] [Abstract][Full Text] [Related]
10. DNA/anti-DNA complexes: correlation of size and complement fixation.
Waller SJ; Taylor RP; Wright EL; Morley KW; Johns M
Arthritis Rheum; 1981 May; 24(5):651-7. PubMed ID: 7236322
[TBL] [Abstract][Full Text] [Related]
11. An enzyme based assay for the measurement of complement mediated binding of immune complexes to red blood cells.
Rafnar BO; Traustadóttir KH; Sigfússon A; Arason GJ; Valdimarsson H; Erlendsson K
J Immunol Methods; 1998 Feb; 211(1-2):171-81. PubMed ID: 9617841
[TBL] [Abstract][Full Text] [Related]
12. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
[TBL] [Abstract][Full Text] [Related]
13. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
14. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Taylor RP; Burge J; Horgan C; Shasby DM
J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
[TBL] [Abstract][Full Text] [Related]
15. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
16. Suramin inhibits the binding of complement-fixing antibody/double-stranded DNA immune complexes to CR1.
Taylor RP; Horgan C; Harbin A; Burge J
Clin Immunol Immunopathol; 1984 Nov; 33(2):220-31. PubMed ID: 6488590
[TBL] [Abstract][Full Text] [Related]
17. Interaction between rheumatoid factor and antibody/DNA complexes: enhancement of complement fixation.
Birchmore DA; Taylor RP; Waller SJ; Davis JS; Morley KW
Arthritis Rheum; 1981 Mar; 24(3):527-33. PubMed ID: 7213431
[TBL] [Abstract][Full Text] [Related]
18. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
19. The interaction of antibody/DNA immune complexes with complement. Influence of antibody class and DNA conformation.
Taylor RP; Edberg JC; Kujala GA; Sloman AJ; Wilson CC; Cronin ME
Arthritis Rheum; 1987 Feb; 30(2):176-85. PubMed ID: 3493781
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
Emlen W; Carl V; Burdick G
Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
